HeartBeam appoints Alan Baumel as COO effective Dec 20, 2021

HeartBeam, Inc.

Annual salary of $200,000, bonus eligibility post-IPO, and option for 1% of post-IPO shares.
Bring 35+ years MedTech experience; previously SVP at Bardy Diagnostics (Hillrom) and roles at Gore, Medtronic, Boston Scientific-acquired firms.
Will lead product development, manufacturing, quality, and regulatory affairs to accelerate commercialization.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan Baumel

Chief Operating Officer

BEAT · HeartBeam, Inc.

Effective: 2021-12-20
Filed: December 27, 2021, 6:59 PM ET

On December 20, 2021, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Alan Baumel as Chief Operating Office of the Company (the “Appointment”) effective as of December 20, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan Baumel was appointed as Chief Operating Officer at HeartBeam, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On December 20, 2021, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Alan Baumel as Chief Operating Office of the Company (the “Appointment”) effective as of December 20, 2021.

View on SEC.gov

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001779372-21-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.